1 |
Aloisi F, Giovannoni G, Salvetti M. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol 2023;22:338-49. [PMID: 36764322 DOI: 10.1016/S1474-4422(22)00471-9] [Reference Citation Analysis]
|
2 |
Guha A, Husain MA, Si Y, Nabors LB, Filippova N, Promer G, Smith R, King PH. RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders. Glia 2023;71:485-508. [PMID: 36380708 DOI: 10.1002/glia.24288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Westfall JJ, Schwind WN, Sran S, Navarro JB, Leonard J, Pindrik JA, Pierson CR, Boué DR, Koboldt DC, Ostendorf AP, Wilson RK, Mardis ER, Miller KE, Bedrosian TA. Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis. Acta Neuropathol Commun 2022;10:168. [PMID: 36411471 DOI: 10.1186/s40478-022-01472-y] [Reference Citation Analysis]
|
4 |
Aloisi F, Veroni C, Serafini B. EBV as the 'gluten of MS' hypothesis: Bypassing autoimmunity. Mult Scler Relat Disord 2022;66:104069. [PMID: 35908445 DOI: 10.1016/j.msard.2022.104069] [Reference Citation Analysis]
|